These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 9680137

  • 21. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
    Burrows SR, Silins SL, Khanna R, Burrows JM, Rischmueller M, McCluskey J, Moss DJ.
    Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
    [Abstract] [Full Text] [Related]

  • 22. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein.
    Kita H, Moriyama T, Kaneko T, Harase I, Nomura M, Miura H, Nakamura I, Yazaki Y, Imawari M.
    Hepatology; 1993 Nov; 18(5):1039-44. PubMed ID: 7693568
    [Abstract] [Full Text] [Related]

  • 23. Identification of hepatitis B virus-specific CTL epitopes presented by HLA-A*33:03 in peripheral blood mononuclear cells from patients and transgenic mice.
    Pan X, Ding H, Zhou X, Tien P.
    Biochem Biophys Res Commun; 2014 Jun 20; 449(1):135-40. PubMed ID: 24813999
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Visual demonstration of hepatitis C virus-specific memory CD8(+) T-cell expansion in patients with acute hepatitis C.
    Sobao Y, Tomiyama H, Nakamura S, Sekihara H, Tanaka K, Takiguchi M.
    Hepatology; 2001 Jan 20; 33(1):287-94. PubMed ID: 11124847
    [Abstract] [Full Text] [Related]

  • 26. Optimized vaccination regimen linked to exhaustive screening approaches identifies 2 novel HLA-B7 restricted epitopes within hepatitis C virus NS3 protein.
    Martin P, Parroche P, Pajot A, Chatel L, Barreto C, Touat L, Dubois V, Rohrlich PS, Bain C, Trépo C, Negro F, Inchauspé G, Fournillier A.
    Microbes Infect; 2006 Aug 20; 8(9-10):2432-41. PubMed ID: 16859951
    [Abstract] [Full Text] [Related]

  • 27. Analysis of the CD8-positive T cell response in Japanese patients with chronic hepatitis C using HLA-A*2402 peptide tetramers.
    Nakamoto Y, Kaneko S, Takizawa H, Kikumoto Y, Takano M, Himeda Y, Kobayashi K.
    J Med Virol; 2003 May 20; 70(1):51-61. PubMed ID: 12629644
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [HCV-specific cytotoxic T lymphocyte and its epitope].
    Morita H, Imawari M.
    Nihon Rinsho; 2004 Jul 20; 62 Suppl 7(Pt 1):155-8. PubMed ID: 15359784
    [No Abstract] [Full Text] [Related]

  • 32. Helper T cell determinant peptide contributes to induction of cellular immune responses by peptide vaccines against hepatitis C virus.
    Hiranuma K, Tamaki S, Nishimura Y, Kusuki S, Isogawa M, Kim G, Kaito M, Kuribayashi K, Adachi Y, Yasutomi Y.
    J Gen Virol; 1999 Jan 20; 80 ( Pt 1)():187-193. PubMed ID: 9934701
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection.
    Guglietta S, Garbuglia AR, Pacciani V, Scottà C, Perrone MP, Laurenti L, Spada E, Mele A, Capobianchi MR, Taliani G, Folgori A, Vitelli A, Ruggeri L, Nicosia A, Piccolella E, Del Porto P.
    Eur J Immunol; 2005 Sep 20; 35(9):2627-37. PubMed ID: 16114108
    [Abstract] [Full Text] [Related]

  • 35. Identification of HLA-A*0201-restricted CD8+ T-cell epitope C₆₄₋₇₂ from hepatitis B virus core protein.
    Liu Q, Zheng Y, Yu Y, Tan Q, Huang X.
    Int Immunopharmacol; 2012 Jun 20; 13(2):141-7. PubMed ID: 22480777
    [Abstract] [Full Text] [Related]

  • 36. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C.
    Nelson DR, Marousis CG, Davis GL, Rice CM, Wong J, Houghton M, Lau JY.
    J Immunol; 1997 Feb 01; 158(3):1473-81. PubMed ID: 9013994
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
    Borghan MA, Oka S, Takiguchi M.
    Tissue Antigens; 2005 Oct 01; 66(4):305-13. PubMed ID: 16185326
    [Abstract] [Full Text] [Related]

  • 39. The loss of immunodominant epitopes affects interferon-gamma production and lytic activity of the human influenza virus-specific cytotoxic T lymphocyte response in vitro.
    Berkhoff EG, Geelhoed-Mieras MM, Verschuren EJ, van Baalen CA, Gruters RA, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.
    Clin Exp Immunol; 2007 May 01; 148(2):296-306. PubMed ID: 17326762
    [Abstract] [Full Text] [Related]

  • 40. Degenerate immunogenicity of an HLA-A2-restricted hepatitis B virus nucleocapsid cytotoxic T-lymphocyte epitope that is also presented by HLA-B51.
    Thimme R, Chang KM, Pemberton J, Sette A, Chisari FV.
    J Virol; 2001 Apr 01; 75(8):3984-7. PubMed ID: 11264388
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.